National Institute of Mental Health; Notice of Closed Meetings, 926 [2020-00111]
Download as PDF
<![CDATA[
jbell on DSKJLSW7X2PROD with NOTICES
926
Federal Register / Vol. 85, No. 5 / Wednesday, January 8, 2020 / Notices
FURTHER INFORMATION CONTACT). Please
provide complete contact information
for each attendee, including name, title,
affiliation, address, email, and
telephone.
Registration is free and based on
space availability, with priority given to
early registrants. Persons interested in
attending this public meeting must
register by 11:59 p.m. Eastern Time on
March 24, 2020. Early registration is
recommended because seating is
limited; therefore, FDA may limit the
number of participants from each
organization.
If you need special accommodations
due to a disability, please contact
Jessica.Berrellez@fda.hhs.gov (see FOR
FURTHER INFORMATION CONTACT) no later
than 11:59 p.m. Eastern Time on March
20, 2020.
Presenters and Panelists: FDA is
interested in gathering scientific and
technical information from individuals
with a broad range of perspectives on
the topics to be discussed at the public
meeting. Presenters and panelists will
discuss their scientific and/or technical
knowledge on the questions and
presentations in each session. Presenters
and panelists will be responsible for
their own travel arrangements.
To be considered to serve as a
presenter and/or panelist, please
provide the following:
• Presenters: A brief abstract for each
presentation. The abstract should
identify the specific topic(s) to be
addressed and the amount of time
requested.
• Presenters and panelists: A onepage biosketch that describes and
supports your scientific or technical
expertise on the specific topic(s) being
presented, nature of your experience
and research in the scientific field,
positions held, and any program
development activities.
If you are interested in serving as a
presenter or a panelist, you must submit
the above information, along with the
topic(s) on which you would like to
speak, to Jessica.Berrellez@fda.hhs.gov
by January 28, 2020.
We will do our best to accommodate
requests to make presentations and
serve on the panel. Individuals and
organizations with common interests are
urged to consolidate or coordinate their
presentations, and request time for a
joint presentation. Following the close
of registration, we will determine the
amount of time allotted to each
presenter and the approximate time
each oral presentation is to begin, and
will select and notify presenters and
panelists by March 6, 2020. If selected
for presentation, any presentation
materials must be emailed to
VerDate Sep<11>2014
17:18 Jan 07, 2020
Jkt 250001
Jessica.Berrellez@fda.hhs.gov no later
than 11:59 p.m. Eastern Time on March
20, 2020. No commercial or promotional
material will be permitted to be
presented or distributed at the public
meeting.
Streaming Webcast of the Public
Meeting: This public meeting will also
be webcast. Please register for the
streaming webcast of the workshop via
https://fdapublicmeetingmodernizing
datastrategy.eventbrite.com by 11:59
p.m. Eastern Time on March 24, 2020.
Pre-registration for the webcast is
recommended, but not required. The
webcast will be available and active
during the public meeting at https://
collaboration.fda.gov/fdadmpm/.
If you have never attended a Connect
Pro event before, test your connection at
https://collaboration.fda.gov/common/
help/en/support/meeting_test.htm. To
get a quick overview of the Connect Pro
program, visit https://www.adobe.com/
go/connectpro_overview. FDA has
verified the website addresses in this
document, as of the date this document
publishes in the Federal Register, but
websites are subject to change over time.
An agenda for the public meeting and
any other background materials will be
made available 5 days before the public
meeting at https://www.fda.gov/newsevents/fda-meetings-conferences-andworkshops/modernizing-fdas-datastrategy-03272020-03272020.
Persons attending FDA’s meetings are
advised that the Agency is not
responsible for providing access to
electrical outlets.
Transcripts: Please be advised that as
soon as a transcript of the public
meeting is available, it will be accessible
at https://www.regulations.gov. It may
be viewed at the Dockets Management
Staff (see ADDRESSES). A link to the
transcript will also be available on the
internet at https://www.fda.gov/newsevents/fda-meetings-conferences-andworkshops/modernizing-fdas-datastrategy-03272020-03272020.
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Refinement and Testing of Interventions to
Sustain ADHD Treatment Effects (R34).
Date: February 10, 2020.
Time: 12:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Marcy Ellen Burstein,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6143, MSC 9606,
Bethesda, MD 20892–9606, 301–443–9699,
bursteinme@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Mental Health Services: Member Conflict.
Date: February 25, 2020.
Time: 12:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Mental Health,
NSC, 6001 Executive Boulevard, Rockville,
MD 20852 (Telephone Conference Call).
Contact Person: Marcy Ellen Burstein,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6143, MSC 9606,
Bethesda, MD 20892–9606, 301–443–9699,
bursteinme@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: January 2, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
Dated: January 3, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–00071 Filed 1–7–20; 8:45 am]
[FR Doc. 2020–00111 Filed 1–7–20; 8:45 am]
BILLING CODE 4164–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meetings
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
E:\FR\FM\08JAN1.SGM
08JAN1
]]>Agencies
[Federal Register Volume 85, Number 5 (Wednesday, January 8, 2020)]
[Notices]
[Page 926]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-00111]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; Refinement and Testing of Interventions to Sustain
ADHD Treatment Effects (R34).
Date: February 10, 2020.
Time: 12:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6101 Executive Boulevard,
Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Marcy Ellen Burstein, Ph.D., Scientific Review
Officer, Division of Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room
6143, MSC 9606, Bethesda, MD 20892-9606, 301-443-9699,
[email protected].
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; Mental Health Services: Member Conflict.
Date: February 25, 2020.
Time: 12:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Mental Health, NSC, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Marcy Ellen Burstein, Ph.D., Scientific Review
Officer, Division of Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room
6143, MSC 9606, Bethesda, MD 20892-9606, 301-443-9699,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.242,
Mental Health Research Grants, National Institutes of Health, HHS)
Dated: January 3, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-00111 Filed 1-7-20; 8:45 am]
BILLING CODE 4140-01-P
